Sartorius Croatia signed an official partnership agreement with the Sartorius Bioanalytics division for the Republic of Croatia and Slovenia. The Bioanalytics portfolio includes instruments for the analysis of proteins and biomolecules, live cells in real-time and flow cytometry.
Sartorius Croatia, as a leading partner and provider of high-tech laboratory equipment and solutions for the biotechnology industry, is proud to announce that on April 24, 2023, it signed an official contract with the Sartorius Bioanalytics subdivision for the Republic of Croatia and Slovenia. This contract enables Sartorius Croatia to distribute and provide technical support for a wide range of advanced analytical instruments and solutions, unique in this region.
We are glad that by concluding a new partnership agreement with the Sartorius Bioanalytics division, we have further strengthened our product portfolio. We are happy to be able to offer our users new, innovative technologies to achieve greater levels of automation and excellence in research and development.
Ivica Granić, CEO of Sartorius Croatia
Devices from the Bioanalytics portfolio include advanced analytical technologies, such as devices for the analysis of proteins and biomolecules based on BLI technology, live cell imaging in real-time inside the incubator, advanced flow cytometry and screening and isolation of cells and colonies.
This collaboration is certainly a step up in the advancement of science and the discovery of medicines on our market. In an effort to be part of your extended scientific team, we are excited to introduce advanced platforms for cell and protein analysis, patented biolayer interferometry, advanced flow cytometry and devices for colony and cell development and screening.
Josipa Smoljo, Sales support for the Bioanalytics division in Sartorius Croatia
Sartorius Croatia strives to provide the best possible support to users in the region, offering sales and consulting services and support for Bioanalytics products in its portfolio. The aim of the cooperation is to improve scientific work and research in the region and to contribute to the development of innovative products and solutions in the biotechnology and pharmaceutical sectors.
Read the official notification letter.